Searched for
IMMUNOTHERAPY RATE
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- 96.6% in CBSE class 10 despite cancer: Topper Aarav Vats’ unbelievable battle with Lymphoma will give you goosebumpsAarav Vats’ remarkable achievement of scoring 96.6% in the CBSE Class 10 examinations, despite battling Lymphoblastic Lymphoma for two year...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- AstraZeneca gets CDSCO approval for Durvalumab in gastric cancer treatmentAstraZeneca Pharma India has secured approval for Durvalumab. This drug, combined with chemotherapy, will treat gastric and gastroesophagea...
- AstraZeneca, Gilead vie for edge in race to treat tough breast cancerNew data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...
- ‘Groundbreaking’: New drugs treating cancer in patients with other cure; Here’s all you need to knowAt the Christie hospital in Manchester, medical professionals are currently overseeing approximately 30 clinical trials. Encouragingly, the...
- AstraZeneca gets CDSCO nod for drug to treat biliary tract cancerDrug firm AstraZeneca India on Friday said it has received approval from the domestic drug regulator to market a drug to treat biliary trac...
- Difficult to scale up expensive therapy beyond a point: Kiran Mazumdar-ShawCAR-T therapies, previously not available in India, have shown promising results for patients who have exhausted all other means of treatme...
- Immuneel's CAR-T cell therapy reports positive in early phase-2 trials in IndiaThe early results from the IMAGINE study were based on the first 10 patients of the planned 24 patients to be enrolled.Both adult and child...
- Adding fruit, nuts & fish to daily diet can help patients with advanced melanoma, says new studyThe Mediterranean diet will play an important role in the success of immunotherapy.
- Allergy signs overlapping with Covid symptoms? Guide to fight stuffy noses & scratchy throatsYou cannot avoid pollen entirely, but there are ways to prevent symptoms.
- Cancer treatment without Chemotherapy? Here is how it could be possibleChemotherapy for decades was considered “the rule, the dogma,” for treating cancer, but various data offer some confirmation that the metho...
- Cancer patients have protective immune response to Covid-19 vaccine: ResearchPatients with cancer were excluded from the clinical trials for the Covid vaccines.
- Top cancer drugs may come under price controlTaking cue from the WHO’s revised list of essential medicines, popular biosimilars for cancer cure may get incorporated in India’s revised ...
- World Cancer Day: Immunotherapy can help patients suffering from carcinoma of the lungsImmunotherapy should be given as early as possible to achieve a lasting remission of the disease.
- Scientists develop new therapeutic antibody for dog cancersTokyo, Aug 26 (IANS) Japanese researchers have developed an antibody that induces immune responses, which significantly suppresses malignan...
- New microneedle patch to help better treat melanomaThese nanoparticles are then loaded into microneedles, which are arrayed on the surface of a patch. When the patch is applied to a melanoma...
- Next-generation anticancer vaccines may beat brain cancerA next-generation cell-based immunotherapy may offer new hope in the fight against the most aggressive form of brain cancer.
- India is so big, we can’t ignore it, we always keep it on our radar: Severin Schwan, Roche CEOSchwan says India’s healthcare spend relative to GDP is very low, compared to economies such as China which spends about 5% to 6% of its GD...
- Major pharma-deals: How anti-cancer drugs are reshaping the pharmaceutical industryNew and considerable optimism over cancer drugs will drive deal-making in pharma over the decade, with companies weak in this segment tryin...
Load More
